Non-Performing Assets / Total Loans: A classification used by financial institutions that refer to loans that are in jeopardy of default as a potion of total loans made. Calculated as: Non-Perfroming Assets / Gross Loans Made
Legend Biotech Corporation Sponsored ADR (LEGN) Non-Performing Assets / Total Loans data is not available.
| Income Statement Financials | |
$627.24M |
|
$-177.03M |
|
$234.58M |
|
$392.66M |
|
$759.34M |
|
$-132.09M |
|
$-26.04M |
|
$-158.13M |
|
$-153.71M |
|
$-177.03M |
|
$-177.03M |
|
$-177.03M |
|
$-173.13M |
|
$-132.09M |
|
$-108.74M |
|
182.85M |
|
182.85M |
|
$-0.96 |
|
$-0.96 |
|
| Balance Sheet Financials | |
$1.28B |
|
$99.29M |
|
$386.24M |
|
$1.67B |
|
$277.64M |
|
$301.20M |
|
$351.96M |
|
$629.61M |
|
$1.04B |
|
$1.04B |
|
$1.04B |
|
183.65M |
|
| Cash Flow Statement Financials | |
$-144.03M |
|
$-850.54M |
|
$5.70M |
|
$1.28B |
|
$286.75M |
|
$-990.96M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.62 |
|
|
Non-Performing Assets / Total Loans |
-- |
-- |
|
0.22 |
|
0.33 |
|
62.60% |
|
-21.06% |
|
-21.06% |
|
-17.34% |
|
-25.21% |
|
-28.22% |
|
$-158.14M |
|
-- |
|
-- |
|
-- |
|
0.38 |
|
9.81 |
|
99.77 |
|
3.66 |
|
-17.01% |
|
-17.05% |
|
-10.60% |
|
-13.19% |
|
$5.67 |
|
$-0.86 |
|
$-0.79 |
|